Government news, all in one place

Medicines and Healthcare products Regulatory Agency

797 articles

Showing 91-120

Yellow Card centre launched in Northern Ireland to strengthen patient safety

Yellow Card centre launched in Northern Ireland to strengthen patient safety

Thursday, 24 July 2025

A new regional centre to promote Yellow Card reporting has been launched in Belfast today....

Read More → press_release
Summer ready: MHRA issues updated guidance on medicines and medical devices during holiday season

Summer ready: MHRA issues updated guidance on medicines and medical devices during holiday season

Wednesday, 23 July 2025

As the UK enters the heart of summer – with temperatures rising and families holidaying –?the Medicines and Healthcare products Regulatory Agency (MHR...

Read More → press_release
Cutting edge personalised treatments, made while you wait, will deliver specialised care to patients more quickly

Cutting edge personalised treatments, made while you wait, will deliver specialised care to patients more quickly

Tuesday, 22 July 2025

New regulations effective today will make it faster and easier for cutting-edge cancer treatments and personalised gene therapies to be made right whe...

Read More → press_release
MHRA announces proposals to improve access to world’s best medical devices for patients and to boost economic growth in Britain’s med tech sector

MHRA announces proposals to improve access to world’s best medical devices for patients and to boost economic growth in Britain’s med tech sector

Tuesday, 22 July 2025

The MHRA has now published the government’s response to its public consultation on future routes to market for medical devices - designed to modernise...

Read More → press_release
The MHRA and the global flu vaccine: How the UK is helping shape the world’s flu vaccine 

The MHRA and the global flu vaccine: How the UK is helping shape the world’s flu vaccine 

Tuesday, 22 July 2025

Ensuring the seasonal flu vaccine is ready, safe and effective involves months of international planning, testing and collaboration...

Read More → news_story
MHRA’s 2024–25 Annual Report and Accounts and Impact Report show progress on safety, innovation, and regulatory excellence

MHRA’s 2024–25 Annual Report and Accounts and Impact Report show progress on safety, innovation, and regulatory excellence

Monday, 21 July 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2024–25 Annual Report and Accounts, and accompanying Impact Report....

Read More → news_story
MHRA approves adrenaline nasal spray   the first needle free emergency treatment for anaphylaxis in the UK

MHRA approves adrenaline nasal spray the first needle free emergency treatment for anaphylaxis in the UK

Friday, 18 July 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) nasal spray (EURneffy) to be...

Read More → press_release
Five non executive directors reappointed to the Medicines and Healthcare products Regulatory Agency Board

Five non executive directors reappointed to the Medicines and Healthcare products Regulatory Agency Board

Thursday, 17 July 2025

Two board members have been reappointed for two years, while three others have had their term extended by a year....

Read More → news_story
MHRA CEO Lawrence Tallon welcomes Life Sciences Sector Plan

MHRA CEO Lawrence Tallon welcomes Life Sciences Sector Plan

Wednesday, 16 July 2025

The Life Sciences Sector plan was released today (16 July 2025)...

Read More → news_story
MHRA approves sebetralstat (Ekterly) to treat hereditary angioedema (HAE) attacks in patients aged 12 and over

MHRA approves sebetralstat (Ekterly) to treat hereditary angioedema (HAE) attacks in patients aged 12 and over

Tuesday, 15 July 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 15 July 2025, approved sebetralstat (Ekterly) for the treatment of hereditar...

Read More → press_release
Government to align with European specifications on high risk in vitro diagnostic devices to reduce regulatory burden 

Government to align with European specifications on high risk in vitro diagnostic devices to reduce regulatory burden 

Thursday, 10 July 2025

The specifications will establish standards for high-risk diagnostic tests while creating consistency with European regulations...

Read More → press_release
Don’t let the heatwave affect your medicines: Three important tips from the MHRA

Don’t let the heatwave affect your medicines: Three important tips from the MHRA

Wednesday, 09 July 2025

Essential advice on protecting your medicines during extreme heat and staying safe this summer....

Read More → press_release
MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (hot flushes) caused by menopause ?

MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (hot flushes) caused by menopause ?

Monday, 07 July 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 8 July, become the first regulator in the world to approve elinzanetant (Lyn...

Read More → press_release
MHRA approves nogapendekin alfa inbakicept to treat adult patients with non muscle invasive bladder cancer??

MHRA approves nogapendekin alfa inbakicept to treat adult patients with non muscle invasive bladder cancer??

Friday, 04 July 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 4 July 2025, approved nogapendekin alfa inbakicept (Anktiva) for adults with...

Read More → news_story
AI Airlock, CERSIs and a new global AI network for health regulators

AI Airlock, CERSIs and a new global AI network for health regulators

Thursday, 26 June 2025

Med Tech Regs blog, June 2025: A focus on Software and AI....

Read More → news_story
If you take a GLP 1 medicine and have been hospitalised by acute pancreatitis, the Yellow Card Biobank wants to hear from you 

If you take a GLP 1 medicine and have been hospitalised by acute pancreatitis, the Yellow Card Biobank wants to hear from you 

Thursday, 26 June 2025

GLP-1 medicines are licensed for Type 2 diabetes and weight management, and include the branded products Ozempic, Mounjaro and Wegovy  ...

Read More → press_release
MHRA seizes 7.7 million doses of illegal medicines and removes hundreds of illegal online listings as part of Operation Pangea

MHRA seizes 7.7 million doses of illegal medicines and removes hundreds of illegal online listings as part of Operation Pangea

Wednesday, 25 June 2025

Operation Pangea brings together health regulators, customs authorities, law enforcement agencies, and private sector partners to tackle the threat po...

Read More → press_release
MHRA publishes final Business Plan for 2023 2026 Corporate Plan 

MHRA publishes final Business Plan for 2023 2026 Corporate Plan 

Wednesday, 25 June 2025

The new Business Plan sets out priorities for 2025–26: Protecting public safety and maintaining public trust; delivering efficient, predictable servic...

Read More → news_story
UK MHRA leads safe use of AI in healthcare as first country in new global network

UK MHRA leads safe use of AI in healthcare as first country in new global network

Monday, 23 June 2025

The MHRA will help shape international rules for AI in healthcare – speeding up access to safe, effective technologies into the NHS and worldwide....

Read More → press_release
AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI powered healthcare innovation

AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI powered healthcare innovation

Monday, 23 June 2025

MHRA opens second round of applications to test cutting-edge AI medical technologies following successful pilot phase....

Read More → press_release
MHRA approves UK’s first anti PD 1 monoclonal antibody for treatment of aggressive form of lung cancer

MHRA approves UK’s first anti PD 1 monoclonal antibody for treatment of aggressive form of lung cancer

Friday, 20 June 2025

As with all products, we will keep its safety under close review...

Read More → press_release
Fast, Expert and Open – how the MHRA is poised to become a global leader in risk proportionate regulation

Fast, Expert and Open – how the MHRA is poised to become a global leader in risk proportionate regulation

Wednesday, 18 June 2025

New MHRA CEO puts safety, accelerated access and innovation at the centre of agency’s refreshed strategic direction....

Read More → press_release
First major overhaul of medical device regulation comes into force across Great Britain

First major overhaul of medical device regulation comes into force across Great Britain

Monday, 16 June 2025

New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor t...

Read More → press_release
Chikungunya vaccine (IXCHIQ) temporarily paused in people aged 65 and over as precautionary measure

Chikungunya vaccine (IXCHIQ) temporarily paused in people aged 65 and over as precautionary measure

Monday, 09 June 2025

This is a precautionary measure while the MHRA conducts the safety review. ...

Read More → news_story
MHRA launches new digital hub in Leeds to drive innovation and regional growth

MHRA launches new digital hub in Leeds to drive innovation and regional growth

Friday, 06 June 2025

The new hub will strengthen the MHRA’s work with regional partners and boost the UK’s digital health and life sciences sector....

Read More → press_release
Helping bring phage medicines to UK patients – guidance for industry

Helping bring phage medicines to UK patients – guidance for industry

Thursday, 05 June 2025

Bacteriophages – viruses that selectively fight bacteria – may offer new hope in fighting infections and tackling antimicrobial resistance....

Read More → press_release
Women on “skinny jabs” must use effective contraception, MHRA urges in latest guidance 

Women on “skinny jabs” must use effective contraception, MHRA urges in latest guidance 

Wednesday, 04 June 2025

Anyone who suspects that they’ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should rep...

Read More → press_release
MHRA approves aumolertinib to treat non small cell lung cancer

MHRA approves aumolertinib to treat non small cell lung cancer

Monday, 02 June 2025

As with all products, we will keep its safety under close review...

Read More → press_release
MHRA approves polihexanide to treat acanthamoeba keratitis

MHRA approves polihexanide to treat acanthamoeba keratitis

Thursday, 22 May 2025

As with any medicine, the MHRA will keep the safety and effectiveness of polihexanide under close review.? ...

Read More → news_story
First MHRA Board meeting held in Scotland, underlining agency’s commitment to regional health equality and growth

First MHRA Board meeting held in Scotland, underlining agency’s commitment to regional health equality and growth

Wednesday, 21 May 2025

The meeting, which took place at the Royal College of Surgeons in Edinburgh, centred on the MHRA’s commitment to delivering the agency’s priorities in...

Read More → press_release

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: